JORDEN DAVID EMERSON (CEO, CFO) received a stock award from NUO THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2026ACC: 0001437749-26-019768
DirectorOfficer· CEO, CFO
Since Aug 2018
+13.24K
Net shares
Net buyer
$14.5K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
13.24K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+13.24K
Price / share
$1.10
Trade value
$14.51K
% of position
0.6%
6/5/2026
2.07M→2.08M
Total
Net shares
+13.24K
Net value
$14.51K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/5/2026 | A · Award | +13.24K | $1.10 | $14.51K | 0.6% | 2.07M | 2.08M |
| Total | +13.24K | $14.51K | ||||||
Derivative Transactions0
No derivative transactions reported